Avita Medical, Inc. Common Stock (RCEL) is a publicly traded Healthcare sector company. As of May 21, 2026, RCEL trades at $4.32 with a market cap of $128.95M and a P/E ratio of -2.74. RCEL moved +3.22% today. Year to date, RCEL is +24.50%; over the trailing twelve months it is -35.52%. Its 52-week range spans $3.22 to $14.16. Analyst consensus is strong buy with an average price target of $7.17. Rallies surfaces RCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Avita Medical, Inc. Common Stock (RCEL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RCEL moved +3.22% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.32 |
| Market Cap | $128.95M |
| P/E Ratio | -2.74 |
| EPS | $-1.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.16 |
| 52-Week Low | $3.22 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $72.35M |
| Net Income | $-45.34M |
| Gross Margin | 81.36% |
4 analysts cover RCEL: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.17.